Blomig P 10 mg/5 mg/325 mg Tablet
By Blomig P
Rx
10 Tablet in a Strip

Composition
Domperidone(10mg) + Flunarizine(5mg) + Paracetamol(325mg)

Manufacturer - Klar Sehen Pvt Ltd
63, N.S.C. Bose Road, 5th Floor, Kolkata, West Bengal, India

Expires on or after
September, 2025

liver
When using Blomig P 10 mg/5 mg/325 mg Tablet, it is important to exercise caution if you have any existing liver disease. In such cases, it may be necessary to adjust the dosage of the tablet. It is crucial to consult your doctor before starting or continuing the use of Blomig P 10 mg/5 mg/325 mg Tablet if you have any liver issues. It is advised not to use this tablet if you have severe liver disease or if your liver disease is actively ongoing. Always seek guidance from your healthcare provider to ensure the safe use of Blomig P 10 mg/5 mg/325 mg Tablet in relation to liver conditions.

kidney
Limited data suggests Blomig P 10 mg/5 mg/325 mg Tablet is likely safe for patients with kidney disease. Consult your doctor as dose adjustment may not be necessary.

alcohol
Consult your doctor when consuming alcohol with Blomig P 10 mg/5 mg/325 mg Tablet.

driving
When using Blomig P 10 mg/5 mg/325 mg Tablet, be cautious as it may reduce alertness, affect vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Blomig P 10 mg/5 mg/325 mg Tablet may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess the benefits versus risks before recommending this medication. Always consult your doctor before using Blomig P 10 mg/5 mg/325 mg Tablet during pregnancy.

breastfeeding
It is better to consult your doctor before using Blomig P 10 mg/5 mg/325 mg Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹40
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025